[Further considerations on therapy and prevention of mongolism].
D000293:Adolescent; D045930:Anabolic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004314:Down Syndrome / Q000188:drug therapy*; D004495:Education of Persons with Intellectual Disabilities; D005971:Glutamates / Q000627:therapeutic use; D005973:Glutamine / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007501:Iron / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D000432:Methanol / Q000627:therapeutic use; D010847:Picolines / Q000627:therapeutic use; D010908:Pituitary Hormones, Anterior / Q000627:therapeutic use; D010924:Placental Extracts / Q000627:therapeutic use
D045930:Anabolic Agents; D005971:Glutamates; D006728:Hormones; D010847:Picolines; D010908:Pituitary Hormones, Anterior; D010924:Placental Extracts; D005973:Glutamine; D008620:Meprobamate; D007501:Iron; D000432:Methanol
Ulteriori considerazioni sulla terpia e la profilassi del mongolismo.